【摘要】 目的:探究MAE方案治疗急性白血病患者的临床疗效。方法:对所有患者均给予MAE方案和相应的支持治疗,观察临床疗效及不良反应。结果:42例患者经MAE方案一个或两个疗程治疗后,完全缓解25例(59.52%),部分缓解8例(19.05%),未缓解9例(21.43%);有38例(占90.48%)患者于治疗6～12d内发生骨髓抑制,23例感染(54.76%),40例(95.24%)患者有轻微消化道反应,无肝肾功能损伤、心肌酶谱改变及死亡者。结论:对急性白血病患者实施MEA治疗方案进行化疗的临床效果确切,且相对安全,值得临床应用与推广。更多还原

【Abstract】 Objective:To explore the clinical efficacy analysis of MAE program for the treatment of patients with acute leukemia.Method:All patients were given the MAE program and appropriate supportive care to observe the clinical efficacy and adverse reactions.Result:42 patients were treated with the MAE program one or two courses ,complete remission in 25 cases(59.52%),partial remission in 8 cases(19.05%),and no relief in 9 cases(21.43%);38 cases(90.48% )in patients with bone marrow suppression in the treatment of 6-12 d,23 cases of infection(54.76%),40 cases (95.24%)patients had mild gastrointestinal reactions,no liver and kidney dysfunction,myocardial enzymes change,and no one died.Conclusion:The exact implementation of the MEA treatment options for chemotherapy has clinical effect in patients with acute leukemia,and is relatively safe,worthy of clinical application and promotion.更多还原